| 注册
首页|期刊导航|神经药理学报|右美托咪定联合利多卡因对颅脑肿瘤手术患者的脑保护作用

右美托咪定联合利多卡因对颅脑肿瘤手术患者的脑保护作用

孙庆田

神经药理学报2024,Vol.14Issue(5):42-46,5.
神经药理学报2024,Vol.14Issue(5):42-46,5.DOI:10.3969/j.issn.2095-1396.2024.05.006

右美托咪定联合利多卡因对颅脑肿瘤手术患者的脑保护作用

Protective Effect of Dexmedetomidine Combined with Lidocaine on Brain in Patients Undergoing Craniocerebral Tumor Surgery

孙庆田1

作者信息

  • 1. 河北中医骨病医院麻醉科,石家庄,050000,中国
  • 折叠

摘要

Abstract

Objective:To investigate the protective effect of dexmedetomidine combined with lidocaine on brain in patients undergoing craniocerebral tumor surgery.Methods:60 patients with craniocerebral tumor surgery were divided into lidocaine group,dexmedetomidine group and combined group according to different anesthesia schemes,20 cases in each group.Rocuronium bromide,sufentanil,propofol and midazolam were used for anesthesia induction.Dexmedetomidine group was given continuous infusion of 0.4 μg·kg-1·h-1 dexmedetomidine during anesthesia maintenance.Lidocaine group was given continuous infusion of 2.0 mg·kg-1·h-1 lidocaine during anesthesia maintenance.Dexmedetomidine 0.2 μg·kg-1·h-1 and lidocaine 1.0 mg·kg-1·h-1 were continuously infused during anesthesia maintenance in the combined group.The levels of serum neuron-specific enolase(NSE),S-100β,inflammatory factors,cognitive function and neurological function were measured.Results:There was no significant difference in serum NSE and S-100β levels among the three groups before administration(T0)(P>0.05).At T1,T2 and T3,the serum NSE and S-100β levels in the lidocaine group were lower than those in the dexmedetomidine group(P<0.05),and the combined group was lower than the lidocaine group(P<0.05).There was no significant difference in the levels of IL-6,TNF-α,hs-CRP and NFA score among the three groups before operation(P>0.05).The levels of IL-6,TNF-α,hs-CRP and NFA score in the lidocaine group were lower than those in the dexmedetomidine group(P<0.05),and those in the combined group were lower than those in the lidocaine group(P<0.05).There was no significant difference in MMSE score among the three groups before operation(P>0.05).After operation,the MMSE score of the lidocaine group was higher than that of the dexmedetomidine group(P<0.05),and the combined group was higher than the lidocaine group(P<0.05).Conclusion:Lidocaine combined with dexmedetomidine can significantly reduce the levels of nerve injury markers and inflammatory factors in craniocerebral tumor surgery,improve postoperative cognitive function and neurological function,and have potential advantages in brain protection.

关键词

右美托咪定/利多卡因/颅脑肿瘤/手术/脑保护

Key words

dexmedetomidine/lidocaine/brain tumor/surgery/brain protection

分类

医药卫生

引用本文复制引用

孙庆田..右美托咪定联合利多卡因对颅脑肿瘤手术患者的脑保护作用[J].神经药理学报,2024,14(5):42-46,5.

神经药理学报

2095-1396

访问量0
|
下载量0
段落导航相关论文